Effects of Antifibrotic Therapy in Patients with Combined Pulmonary Fibrosis and Emphysema: A US-Based Cohort Study.

Biomedicines · 2025 · PMC12561162 · PMID 41153803

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Regarding the primary outcomes, the five-year follow-up after the index event showed a trend towards a higher risk of mortality in CPFE patients with antifibrotic use compared to patients without antifibrotic outcomes (HR: 1.14; CI 0.99–1.33; p 0.06), as listed in Table 2 .

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.